Review study finds limited data on medical cannabis use in children

A systematic review of published studies on the use of medical cannabis in children and adolescents finds a notable lack of studies and a minimal number of the randomized, controlled trials needed to confirm the effectiveness of a treatment In their paper published in the journal Pediatrics, Massachusetts General Hospital (MGH) investigators Shane Shucheng Wong, MD,…

Mother ‘forced’ to buy cannabis to feed to her nine-year-old daughter

Doctors refuse to prescribe illegal drug to treat the girl’s seizures A mother has been forced to make cannabis oil at home to treat her nine-year-old daughter’s seizures because the Australian government refuses to legalise it. Katrina Spraggon from Queensland’s Sunshine Coast has been petitioning lawmakers for three years to no avail, even when they…

Daily cannabis and reduced risk of steatosis in human immunodeficiency virus and hepatitis C virus co-infected patients (ANRS CO13-HEPAVIH)

Liver steatosis is common in Human Immunodeficiency Virus (HIV) – Hepatitis C Virus (HCV) co-infected patients. Some recent studies have found that cannabis use is negatively associated with insulin resistance in the general population and in HIV-HCV co-infected patients. Given the causal link between insulin resistance and steatosis, we hypothesised that cannabis use has a positive impact on steatosis.

The use of cannabis in response to the opioid crisis: A review of the literature

Review of the current literature suggests states that implement MC policies could reduce POM-associated mortality, improve pain management, and significantly reduce health care costs. However, MC research is constrained by federal policy restrictions, and more research related to MC as a potential alternative to POM for pain management, MC harms, and its impact on POM-related harms and health care costs should be a priority of public health, medical, and nursing research.